{"id":"W3084510417","doi":"10.3747/co.27.6439","title":"Nivolumab and Ipilimumab Immunotherapy for Hemodialysis Patients with Advanced Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Renal cell carcinoma; Blockade; Adverse effect; Immune checkpoint; Hemodialysis; Oncology; Internal medicine; Immunotherapy; Cancer; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001972059,0.0001204469,0.000261263,0.0001920307,0.0003801704,0.0002446297,0.000121398,0.0004310624,0.0004320302],"category_scores_gemma":[0.0004308291,0.00005105174,0.0002552229,0.0001453613,0.0001873196,0.0002093321,0.0001628033,0.0005150108,0.0001131072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002728405,"about_ca_system_score_gemma":0.0003212001,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004523189,"about_ca_topic_score_gemma":0.001021012,"domain_scores_codex":[0.9999121,0.0000273234,0.00001211484,0.00001304002,0.00001588643,0.00001942428],"domain_scores_gemma":[0.9998538,0.00005566807,0.00002427328,0.000009251859,0.000009878125,0.00004694549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004051997,0.001765067,0.3864414,0.0005180416,0.0002589111,0.2881682,0.001122166,0.00150299,0.07181662,0.0009639428,0.004065515,0.2393253],"study_design_scores_gemma":[0.0006961804,0.01108281,0.3447989,0.0001815945,0.0003795707,0.5590325,0.000800901,0.008377668,0.03475862,0.001499938,0.03832828,0.00006304942],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869863,0.006086775,0.001160619,0.001348594,0.00009239094,0.00006503236,0.00003614887,0.00003230343,0.004191764],"genre_scores_gemma":[0.997739,0.0008435362,0.000591701,0.0003762815,0.0001165983,0.00001078073,0.00002612747,0.000002120031,0.0002939646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0004523189,"threshold_uncertainty_score":0.001979589,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03560789113485781,"score_gpt":0.3146710221367576,"score_spread":0.2790631310018998,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}